PROTAC Synthesis and Optimization Services

Name: Custom PROTAC Synthesis Services
Brand: BOC Sciences

Custom PROTAC synthesis requires far more than connecting a target protein ligand, linker, and E3 ligase ligand. For pharmaceutical and biotechnology teams, the main challenge is often translating a promising degradation concept into synthetically accessible, analytically traceable, and biologically meaningful degrader candidates. PROTAC molecules frequently present high molecular weight, flexible linkers, multiple stereocenters, poor solubility, difficult purification behavior, and strong sensitivity to linker length or exit-vector geometry. BOC Sciences provides custom PROTAC synthesis services for discovery researchers, medicinal chemists, and drug development scientists who need tailored degraders, analog libraries, ligand-linker intermediates, and synthesis-ready optimization strategies. By integrating PROTAC design services, medicinal chemistry, linker engineering, and analytical characterization, we help clients move efficiently from degrader concept to experimentally usable compounds for targeted protein degradation research.

Request a Consultation Explore Services

Services

BOC Sciences Custom PROTAC Synthesis Capabilities

De Novo PROTAC Molecule Synthesis We synthesize customized bifunctional degraders based on client-provided structures, literature-inspired concepts, or jointly developed designs. Our team supports complete PROTAC assembly from POI ligand, linker, and E3 ligase ligand building blocks, including route scouting, protecting-group strategy, coupling chemistry selection, purification, and structural confirmation for complex degrader scaffolds.
Linker Design and Optimization Linker composition, length, rigidity, polarity, and attachment site can determine whether a PROTAC forms a productive ternary complex. We design and synthesize PEG, alkyl, heteroatom-rich, rigid, semi-rigid, cleavable, and branching linker series to tune spatial orientation, permeability, solubility, and degradation performance.
E3 Ligase Ligand Conjugation BOC Sciences supports the incorporation of commonly used and emerging E3 ligase recruiting motifs, including CRBN-, VHL-, IAP-, and MDM2-oriented ligand systems. Through ligand design for E3 ligase workflows, we help clients select suitable exit vectors, functional handles, and conjugation-ready intermediates for efficient degrader construction.
Target Ligand-Linker Intermediate Synthesis For programs with validated inhibitors, binders, or fragment-derived ligands, we prepare target ligand-linker intermediates with defined attachment points and optimized chemical handles. Our ligand design for target protein support helps preserve binding interactions while enabling efficient downstream PROTAC assembly.
PROTAC Analog Library Synthesis To support SAR and structure-degradation relationship studies, we design and synthesize focused analog libraries varying linker length, linker chemistry, E3 ligand class, POI ligand exit vector, stereochemistry, and physicochemical balance. Clients may also combine custom synthesis with our PROTAC library resources for faster hit expansion.
Analytical Characterization and Research-Grade Reporting Each synthesized PROTAC can be supported with analytical data packages according to project needs, including LC-MS, HRMS, NMR, HPLC, and stability-oriented observations. Our chemists provide interpretation of synthetic feasibility, impurity behavior, chromatographic challenges, and recommended next-round optimization directions.

Need a Custom PROTAC Built Around Your Target?

From linker selection to full degrader assembly, BOC Sciences delivers tailored synthesis strategies for challenging protein degradation projects.

Get a Quote

Platforms

Technical Platforms Supporting Custom PROTAC Synthesis

Medicinal Chemistry Route Development Our synthesis platform supports route scouting and reaction optimization for high-complexity degraders, including late-stage coupling, parallel synthesis, and functional-group-tolerant assembly. Amide coupling, click chemistry, reductive amination, alkylation, urea formation, and carbamate formation Multi-step synthesis of ligand-linker and E3 ligand-linker intermediates Protecting-group design for heteroatom-rich and stereochemically complex scaffolds
Computational Design-Guided Synthesis When target structures or ligand-bound models are available, synthesis planning can be guided by molecular geometry, exit-vector analysis, and degrader conformational assessment. Molecular docking for protein-ligand interaction evaluation Virtual screening for ligand and degrader concept selection Exit-vector and linker distance-window assessment
Linker and Building Block Chemistry We prepare linker fragments and bifunctional building blocks that allow rapid expansion of degrader analogs while maintaining consistent synthetic logic across a project. PEG, alkyl, piperazine, triazole, aromatic, and mixed-polarity linkers Azide, alkyne, amine, acid, NHS ester, halide, and activated carbonate handles Modular linker-containing intermediates for iterative SAR synthesis
Physicochemical Property Optimization Because PROTACs often exceed traditional small-molecule property ranges, our chemists evaluate structural modifications that improve handling, solubility, and stability without compromising degrader architecture. Polarity and lipophilicity balancing through linker and scaffold changes Solubility and stability evaluation for research-use compounds Salt-form, counterion, and formulation-compatible handling recommendations
Biophysical and Degradation-Oriented Assay Interface Custom synthesis can be connected with binding and degradation assessment to help clients understand whether a synthetic series is moving toward productive target engagement. Binding affinity measurement for POI and E3 ligand interactions PROTAC ternary complex assay support Target degradation readouts including DC₅₀, D_max, and time-course analysis
Analytical and Structural Confirmation We combine orthogonal analytical methods to confirm identity, evaluate synthetic consistency, and troubleshoot difficult purification profiles common in large bifunctional molecules. LC-MS, HRMS, HPLC, NMR, and chiral analysis when applicable Fragment, intermediate, and final PROTAC characterization Technical summary reports with route notes and optimization suggestions

Advantages

Why Custom PROTAC Synthesis Requires Specialized Expertise?

Complex Three-Part Molecular Architecture

A productive PROTAC depends on the correct pairing of POI ligand, linker, and E3 ligase ligand. Small changes in attachment point, length, or flexibility can substantially alter ternary complex formation and degradation activity.

Difficult Purification Behavior

Large, amphiphilic, and conformationally flexible PROTACs often show broad chromatographic peaks, strong adsorption, or overlapping impurity profiles. Our purification strategies are adjusted to each scaffold rather than applying a generic small-molecule workflow.

SAR Requires Iterative Analog Synthesis

PROTAC optimization is rarely linear. We support parallel analog synthesis to explore linker chemistry, E3 ligand choice, exit-vector location, and stereochemical effects across multiple design cycles.

Chemistry Must Align with Biology

Custom synthesis is designed with downstream biology in mind, including cellular permeability, target engagement, degradation kinetics, and compatibility with PROTAC in vitro evaluation.

Workflow

Our Custom PROTAC Synthesis Service Workflow

01

Project Consultation and Structure Review

We review target protein information, available ligands, desired E3 ligase recruiter, proposed linker, intended assay format, compound quantity needs, and known synthetic or solubility constraints.

02

Retrosynthetic Analysis and Feasibility Assessment

Our chemists evaluate coupling order, functional-group compatibility, protecting-group requirements, purification risks, and alternative routes to reduce synthetic uncertainty before laboratory execution.

03

Building Block and Intermediate Preparation

We synthesize or source POI ligand derivatives, E3 ligand derivatives, linker fragments, and activated intermediates with suitable chemical handles for final PROTAC assembly.

04

Full PROTAC Assembly

The bifunctional degrader is assembled through optimized coupling chemistry, with reaction monitoring and condition adjustment to address low conversion, instability, or side-product formation.

05

Purification and Structural Confirmation

Final compounds are purified using scaffold-appropriate methods and characterized by analytical techniques such as LC-MS, HRMS, HPLC, and NMR according to project design.

06

Analog Expansion and SAR Support

Based on initial results, we can prepare focused analog sets to test linker length, polarity, E3 ligand preference, exit-vector effects, and stereochemical contributions to degradation potency.

07

Optional Degradation and Binding Evaluation

Synthesized PROTACs can be connected with degradation ability assay workflows to assess target knockdown, potency ranking, and early structure-degradation relationships.

08

Data Delivery and Next-Round Design Guidance

We provide compound data, synthesis notes, analytical summaries, and practical recommendations for the next design cycle, helping teams prioritize the most promising degrader series.

Start Your Custom PROTAC Synthesis Project

Share your target, ligand structure, or degrader concept with BOC Sciences to receive a tailored synthesis strategy.

Talk to Experts

Why Us

BOC Sciences Advantages in Custom PROTAC Synthesis

Integrated Chemistry and Degrader Expertise

Our team understands both synthetic chemistry and targeted protein degradation design, enabling synthesis decisions that support biological interpretation rather than merely delivering isolated compounds.

Flexible Entry Points

Clients may request single-compound synthesis, linker intermediate preparation, analog library synthesis, route troubleshooting, or integrated design-synthesis-assay support depending on project maturity.

Experience with Challenging Scaffolds

We routinely work with high molecular weight, highly polar, hydrophobic, chiral, and conformationally flexible degrader molecules that require customized handling and purification approaches.

Modular Analog Generation

Our building-block strategy enables rapid preparation of analog sets, helping clients compare E3 ligase recruiters, linker types, and ligand attachment points across a coherent SAR plan.

Transparent Technical Communication

Project teams receive route rationale, synthesis updates, analytical interpretation, and next-step suggestions to support confident decision-making throughout degrader development.

Connection to Broader TPD Platforms

Custom PROTAC synthesis can be integrated with target analysis, ligand optimization, ubiquitination assays, ternary complex evaluation, and degradation assays for a more complete research workflow.

Applications

Applications of Custom PROTAC Synthesis Services

Hit Validation in Targeted Protein Degradation

Custom synthesis enables researchers to convert promising ligand pairs into complete degraders for testing whether target engagement can be translated into protein degradation.

Lead Optimization and SAR Expansion

Focused PROTAC analog synthesis helps teams investigate how linker structure, ligand orientation, physicochemical balance, and E3 ligase selection affect DC₅₀, D_max, selectivity, and degradation kinetics.

Kinase Degrader Discovery

Kinase inhibitors can be converted into degraders for targets such as BTK, CDK, JAK, EGFR, FAK, PI3K, ALK, and ERK-related pathways, supporting mechanistic research and degrader optimization.

Transcription Factor and Epigenetic Target Research

PROTAC synthesis can support degrader exploration for challenging nuclear proteins, including BET family proteins, transcriptional regulators, chromatin-associated proteins, and other difficult-to-inhibit targets.

Negative Control and Mechanism-of-Action Studies

We synthesize inactive analogs, stereochemical controls, E3-binding-deficient controls, and linker-modified variants to help distinguish degradation-driven effects from binding-only or off-target responses.

Custom Building Blocks for Degrader Programs

BOC Sciences prepares ligand-linker conjugates, E3 ligand-linker conjugates, activated linker fragments, and other customized intermediates that streamline internal degrader discovery workflows.

Case Study

Client Success Stories: Custom PROTAC Synthesis

Project Background

A US-based biotechnology company was developing a BTK-targeting degrader series using an ibrutinib-inspired kinase ligand and a CRBN-recruiting ligand. The client had identified one active prototype but needed a broader analog set to understand whether linker length, polarity, and attachment geometry could improve cellular degradation while maintaining acceptable compound handling characteristics.

Technical Challenges

The initial molecule displayed poor aqueous handling, strong retention during purification, and variable recovery after preparative chromatography. The client also needed multiple analogs that preserved the same BTK ligand core while varying only the linker and E3 ligand exit-vector region, requiring a modular and comparable synthesis plan.

BOC Sciences Solutions

Route Redesign: We changed the coupling sequence to prepare a stable BTK ligand-linker intermediate first, followed by late-stage attachment of CRBN ligand derivatives. This reduced repeated exposure of the complete PROTAC to harsh conditions.
Linker Matrix Construction: We synthesized 28 analogs covering PEG₂-PEG₅, alkyl-PEG hybrid, triazole-containing, and piperazine-containing linkers to evaluate length, flexibility, and polarity effects.
Purification Optimization: We screened acidic, neutral, and buffered chromatographic conditions and selected a method that improved peak shape and recovery for the most hydrophobic analogs.

Project Outcomes

BOC Sciences delivered a structurally confirmed 28-compound BTK PROTAC analog panel. The best-performing analog contained a semi-flexible PEG-alkyl linker and showed stronger BTK degradation than the original prototype in the client's cell-based screen. The final dataset helped the client identify a preferred linker length window and prioritize six compounds for deeper in vitro degradation profiling.

Project Background

A European pharmaceutical discovery team sought to synthesize a covalent PROTAC directed toward a mutant KRAS protein. The proposed structure incorporated a covalent warhead-bearing target ligand, a VHL ligand, and a polar linker designed to reduce excessive hydrophobicity. Early internal attempts generated low conversion and multiple side products during final-stage coupling.

Technical Challenges

The electrophilic warhead was sensitive to basic conditions, while the VHL ligand intermediate required careful protection and deprotection control. The final PROTAC also showed limited solubility in several reaction and purification systems, complicating isolation and analytical confirmation.

BOC Sciences Solutions

Warhead-Compatible Route Exploration: We evaluated four synthetic sequences and selected a route that introduced the covalent warhead at the final stage under milder conditions.
Alternative Linker Activation: We compared acid chloride, activated ester, and carbamate-forming approaches, ultimately selecting an activated carbonate strategy to improve conversion while limiting degradation of the target ligand.
Analytical Troubleshooting: We used LC-MS-guided monitoring to identify a key hydrolysis side product and adjusted solvent composition and reaction water content to suppress its formation.

Project Outcomes

BOC Sciences established a workable route and synthesized eight KRAS-targeted covalent PROTAC analogs. The optimized route improved isolated recovery of the lead structure compared with the client's initial approach and generated enough material for target engagement, ternary complex, and degradation studies. One VHL-based analog with a short polar linker showed the most favorable balance of handling properties and cellular activity in the client's follow-up assays.

Frequently Asked Questions (FAQ)

Frequently Asked Questions

Still have questions?

Contact Us

What projects need custom PROTAC synthesis?

Custom PROTAC synthesis is suitable for drug discovery teams that have identified a target protein, a binding ligand, or an initial degrader concept but need chemically reliable molecules for optimization studies. Many projects begin with known POI ligands, E3 ligase ligands, or reported degrader scaffolds, yet still require systematic linker variation, conjugation-site adjustment, solubility improvement, and structure confirmation. BOC Sciences supports custom synthesis from early degrader design to focused analog libraries, helping clients explore CRBN-, VHL-, IAP-, or other E3-based strategies while balancing synthetic feasibility, molecular properties, and downstream biological evaluation needs.

How do you select an E3 ligase ligand?

E3 ligase ligand selection depends on the target biology, cell model, available structural information, and the intended degradation mechanism. CRBN and VHL ligands are widely used, but they are not automatically the best choice for every target. A productive PROTAC must bring the protein of interest and the E3 ligase into a favorable ternary complex, so the E3 ligand, exit vector, and linker attachment point all matter. BOC Sciences can design comparative PROTAC sets using different E3 ligase ligands and linker orientations, allowing clients to evaluate which architecture provides the most promising degradation profile for their research program.

Why is linker optimization so important?

The linker determines the distance, flexibility, orientation, polarity, and conformational behavior between the target-binding ligand and the E3 ligase ligand. A linker that is too short may create steric conflict, while a linker that is too long or overly flexible may weaken productive ternary complex formation. Linker composition can also influence solubility, permeability, aggregation tendency, and cellular degradation activity. BOC Sciences offers customized linker design using PEG chains, alkyl linkers, rigid spacers, cleavable motifs, and functionalized handles, enabling clients to compare multiple degrader candidates and identify structures with improved DC50, Dmax, and cellular activity.

Can PROTACs be made without a mature ligand?

PROTAC development is possible without a fully mature target ligand, but the project usually requires a staged discovery strategy. The first step is to identify or optimize a suitable POI-binding molecule through reported inhibitors, fragment-like binders, structure-guided design, or ligand modification. Once a binding motif is available, the attachment site must be assessed carefully to avoid disrupting target engagement. BOC Sciences can help evaluate whether a ligand is suitable for degrader construction, then design initial PROTAC candidates with different linker positions and E3 ligase partners. This approach helps clients explore degradation feasibility while reducing unnecessary synthesis of poorly designed molecules.

How are synthesized PROTAC candidates evaluated?

Synthesized PROTAC candidates should be evaluated through both chemical characterization and functional degradation analysis. Structural confirmation by LC-MS, HRMS, NMR, and chromatographic methods helps verify molecular identity and consistency, while biological assays can compare target engagement, degradation efficiency, concentration response, and time-dependent activity. BOC Sciences can support clients by integrating synthesis with in vitro evaluation strategies such as Western blot, ELISA, cell viability assays, and degradation profiling. Because PROTAC performance is influenced by molecular size, linker properties, cell permeability, and ternary complex formation, a complete evaluation should connect structural design with functional readouts rather than relying on a single activity measurement.

Testimonials

Client Testimonials on Custom PROTAC Synthesis

Efficient Synthesis of a Difficult Degrader

“Our internal chemistry team struggled with the final coupling step of a high molecular weight PROTAC. BOC Sciences redesigned the route, improved reaction monitoring, and delivered a compound set that allowed us to continue our degradation study without changing the core design.”

— Principal Scientist at a US-based Biotechnology Company

Practical Linker SAR Support

“The BOC Sciences team did not simply synthesize what we requested. They helped us build a rational linker matrix and explained how each analog could answer a specific SAR question. That made our follow-up biological results much easier to interpret.”

— Director of Medicinal Chemistry at a European Pharma Group

Strong Communication Throughout the Project

“Our PROTAC series was chemically challenging, and several analogs required troubleshooting. BOC Sciences provided clear technical updates, realistic recommendations, and useful analytical summaries that helped our project team make fast decisions.”

— Senior Project Manager at a Targeted Degradation Startup

Reliable Support for Degrader Discovery

“We needed custom E3 ligand-linker intermediates and final PROTACs for a kinase degrader program. The compounds were well characterized, and the synthesis notes gave our internal team a clear path for the next design cycle.”

— Lead Chemist at an Oncology Research Organization